These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3023611

  • 1. Comparison of (-)-eseroline with (+)-eseroline and dihydroseco analogues in antinociceptive assays: confirmation of rubreserine structure by X-ray analysis.
    Schönenberger B, Jacobson AE, Brossi A, Streaty R, Klee WA, Flippen-Anderson JL, Gilardi R.
    J Med Chem; 1986 Nov; 29(11):2268-73. PubMed ID: 3023611
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Eseroline: a new antinociceptive agent derived from physostigmine with opiate receptor agonist properties. Experimental in vivo and in vitro studies on cats and rodents.
    Bartolini A, Renzi G, Galli A, Aiello PM, Bartolini R.
    Neurosci Lett; 1981 Sep 01; 25(2):179-83. PubMed ID: 7279315
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of acetylcholinesterase from electric eel by (-)-and (+)-physostigmine and related compounds.
    Brossi A, Schönenberger B, Clark OE, Ray R.
    FEBS Lett; 1986 Jun 09; 201(2):190-2. PubMed ID: 3709808
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Eseroline depresses the responses of dorsal horn neurons to C-fiber afferents in the spinal rat.
    Braga PC, Biella G, Fraschini F, Tiengo M.
    Neurosci Lett; 1986 Oct 30; 71(1):113-7. PubMed ID: 2878395
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of eseroline, an opiate like drug, on the rat nociceptive thalamic neurons activated by peripheral noxious stimuli.
    Braga PC, Tiengo M, Biella G, Dall'Oglio G, Fraschini F.
    Brain Res; 1984 Mar 26; 296(1):177-80. PubMed ID: 6143592
    [Abstract] [Full Text] [Related]

  • 10. Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivity.
    Burke TR, Jacobson AE, Rice KC, Silverton JV, Simonds WF, Streaty RA, Klee WA.
    J Med Chem; 1986 Jun 26; 29(6):1087-93. PubMed ID: 3012085
    [Abstract] [Full Text] [Related]

  • 11. In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
    Galli A, Malmberg Aiello P, Renzi G, Bartolini A.
    J Pharm Pharmacol; 1985 Jan 26; 37(1):42-8. PubMed ID: 2858526
    [Abstract] [Full Text] [Related]

  • 12. Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
    Yu QS, Atack JR, Rapoport SI, Brossi A.
    FEBS Lett; 1988 Jul 04; 234(1):127-30. PubMed ID: 3391264
    [Abstract] [Full Text] [Related]

  • 13. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
    Yu Q, Greig NH, Holloway HW, Brossi A.
    J Med Chem; 1998 Jun 18; 41(13):2371-9. PubMed ID: 9632370
    [Abstract] [Full Text] [Related]

  • 14. Effect of eseroline on schedule-controlled behavior in the rat.
    Liu WF.
    Pharmacol Biochem Behav; 1991 Apr 18; 38(4):747-51. PubMed ID: 1871191
    [Abstract] [Full Text] [Related]

  • 15. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases.
    Atack JR, Yu QS, Soncrant TT, Brossi A, Rapoport SI.
    J Pharmacol Exp Ther; 1989 Apr 18; 249(1):194-202. PubMed ID: 2709330
    [Abstract] [Full Text] [Related]

  • 16. Further explorations of unnatural alkaloids.
    Brossi A.
    J Nat Prod; 1985 Apr 18; 48(6):878-93. PubMed ID: 3879267
    [Abstract] [Full Text] [Related]

  • 17. Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-methylfentanyl isothiocyanate, a potent site-directed acylating agent for the delta opioid receptors in vitro.
    Kim CH, Rothman RB, Jacobson AE, Mattson MV, Bykov V, Streaty RA, Klee WA, George C, Long JB, Rice KC.
    J Med Chem; 1989 Jun 18; 32(6):1392-8. PubMed ID: 2542560
    [Abstract] [Full Text] [Related]

  • 18. Simple liquid chromatographic method for the determination of physostigmine and its metabolite eseroline in rat plasma: application to a pharmacokinetic study.
    Zhao B, Moochhala SM, Chaw CS, Yang YY.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb 05; 784(2):323-9. PubMed ID: 12505780
    [Abstract] [Full Text] [Related]

  • 19. N-substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines.
    Cheng A, Uyeno E, Polgar W, Toll L, Lawson JA, DeGraw JI, Loew G, Camerman A, Camerman N.
    J Med Chem; 1986 Apr 05; 29(4):531-7. PubMed ID: 3007760
    [Abstract] [Full Text] [Related]

  • 20. Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?
    Jacquet YF, Klee WA, Rice KC, Iijima I, Minamikawa J.
    Science; 1977 Nov 25; 198(4319):842-5. PubMed ID: 199942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.